Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 APOE {epsilon}4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics.

× No keyword cloud information.

6 in total

Review 1. Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors: Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal: Lancet Neurol Date: 2011-03 Impact factor: 44.182

2. MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia.

Authors: J W Ashford; M Adamson; T Beale; D La; B Hernandez; A Noda; A Rosen; R O'Hara; J K Fairchild; D Spielman; J A Yesavage
Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472

Review 3. Immunotherapy for Alzheimer disease: the challenge of adverse effects.

Authors: Yu-Hui Liu; Brian Giunta; Hua-Dong Zhou; Jun Tan; Yan-Jiang Wang
Journal: Nat Rev Neurol Date: 2012-07-03 Impact factor: 42.937

Review 4. Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors: Sam Gandy; Steven T DeKosky
Journal: Annu Rev Med Date: 2013 Impact factor: 13.739

5. Alzheimer's disease: diagnostics, prognostics and the road to prevention.

Authors: Iris Grossman; Michael W Lutz; Donna G Crenshaw; Ann M Saunders; Daniel K Burns; Allen D Roses
Journal: EPMA J Date: 2010-06-29 Impact factor: 6.543

6. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.

Authors: Joanna E Pankiewicz; Maitea Guridi; Jungsu Kim; Ayodeji A Asuni; Sandrine Sanchez; Patrick M Sullivan; David M Holtzman; Martin J Sadowski
Journal: Acta Neuropathol Commun Date: 2014-06-28 Impact factor: 7.801

6 in total